Shoshana Shendelman - Jan 7, 2022 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Shoshana Shendelman
Stock symbol
APLT
Transactions as of
Jan 7, 2022
Transactions value $
$0
Form type
4
Date filed
1/11/2022, 05:45 PM
Previous filing
Jan 11, 2022
Next filing
Jan 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +121K +24.92% $0.00 606K Jan 7, 2022 Direct F1
holding APLT Common Stock 1.75M Jan 7, 2022 See footnote F2
holding APLT Common Stock 1.49M Jan 7, 2022 See footnote F3
holding APLT Common Stock 710K Jan 7, 2022 See footnote F4
holding APLT Common Stock 290K Jan 7, 2022 See footnote F5
holding APLT Common Stock 88.4K Jan 7, 2022 See footnote F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLT Employee Stock Option (Right to Buy) Award $0 +80.6K $0.00 80.6K Jan 7, 2022 Common Stock 80.6K $4.17 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on January 7, 2023, and one-twelfth (1/12th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each quarter thereafter, subject to the Reporting Person continuing to provide services through each such date.
F2 Through a grantor retained annuity trust.
F3 Through a family trust controlled by the reporting person's spouse.
F4 Through the reporting person's spouse.
F5 Through a family trust controlled by the reporting person.
F6 Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.
F7 Consists of compensatory Options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on January 7, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.